Agency Information Collection Activities: Proposed Collection; Comments Requested, 33775 [E7-11783]

Download as PDF Federal Register / Vol. 72, No. 117 / Tuesday, June 19, 2007 / Notices desires to manufacture a quantity of such class, or who desires to manufacture using the List I chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, must apply on DEA Form 189 for a manufacturing quota for such quantity of such class or List I chemical. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that each form takes 0.5 hours (30 minutes) to complete. In total, 37 firms submit 298 responses, with each response taking 0.5 hours (30 minutes) to complete. This results in a total public burden of 149 hours annually. (6) An estimate of the total public burden (in hours) associated with the collection: In total, 37 firms submit 298 responses, with each response taking 0.5 hours (30 minutes) to complete. This results in a total public burden of 149 hours annually. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. Dated: June 12, 2007. Lynn Bryant, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. E7–11782 Filed 6–18–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0008] Agency Information Collection Activities: Proposed Collection; Comments Requested 60-Day Notice of Information Collection Under Review: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine DEA Form 250. rwilkins on PROD1PC63 with NOTICES ACTION: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until August 20, 2007. This process is VerDate Aug<31>2005 18:32 Jun 18, 2007 Jkt 211001 conducted in accordance with 5 CFR 1320.10. If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Mark W. Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this Information Collection (1) Type of Information Collection: Extension of an existing collection. (2) Title of the Form/Collection: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine. (3) Agency form number, if any and the applicable component of the Department sponsoring the collection: Form number: DEA Form 250. Component: Office of Diversion Control, Drug Enforcement Administration, U.S. Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: None. Abstract: 21 U.S.C. 826 and 21 CFR 1303.12 and 1315.32 require that U.S. companies who desire to use any basic class of controlled substances listed in Schedule I or II or the List I chemicals ephedrine, pseudoephedrine, and PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 33775 phenylpropanolamine for purposes of manufacturing during the next calendar year shall apply on DEA Form 250 for procurement quota for such class or List I chemical. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that each form takes 1 hour to complete. DEA estimates that 495 individual respondents will respond to this form. DEA estimates that 1,346 responses are received annually. (6) An estimate of the total public burden (in hours) associated with the collection: The total public burden for this collection is 1,346 hours annually. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. Dated: June 12, 2007. Lynn Bryant, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. E7–11783 Filed 6–18–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0047] Agency Information Collection Activities 60–Day Notice of Information Collection Under Review. Proposed collection; comments requested: Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine DEA Form 488. ACTION: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until August 20, 2007. This process is conducted in accordance with 5 CFR 1320.10. If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Mark W. Caverly, Chief, E:\FR\FM\19JNN1.SGM 19JNN1

Agencies

[Federal Register Volume 72, Number 117 (Tuesday, June 19, 2007)]
[Notices]
[Page 33775]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-11783]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0008]


Agency Information Collection Activities: Proposed Collection; 
Comments Requested

ACTION: 60-Day Notice of Information Collection Under Review: 
Application for Procurement Quota for Controlled Substances and 
Ephedrine, Pseudoephedrine, and Phenylpropanolamine DEA Form 250.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA), will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. Comments are encouraged and will be accepted 
until August 20, 2007. This process is conducted in accordance with 5 
CFR 1320.10.
    If you have comments, especially on the estimated public burden or 
associated response time, suggestions, or need a copy of the proposed 
information collection instrument with instructions or additional 
information, please contact Mark W. Caverly, Chief, Liaison and Policy 
Section, Office of Diversion Control, Drug Enforcement Administration, 
Washington, DC 20537.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agencies estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of this Information Collection

    (1) Type of Information Collection: Extension of an existing 
collection.
    (2) Title of the Form/Collection: Application for Procurement Quota 
for Controlled Substances and Ephedrine, Pseudoephedrine, and 
Phenylpropanolamine.
    (3) Agency form number, if any and the applicable component of the 
Department sponsoring the collection:
    Form number: DEA Form 250.
    Component: Office of Diversion Control, Drug Enforcement 
Administration, U.S. Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: None.
    Abstract: 21 U.S.C. 826 and 21 CFR 1303.12 and 1315.32 require that 
U.S. companies who desire to use any basic class of controlled 
substances listed in Schedule I or II or the List I chemicals 
ephedrine, pseudoephedrine, and phenylpropanolamine for purposes of 
manufacturing during the next calendar year shall apply on DEA Form 250 
for procurement quota for such class or List I chemical.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: DEA estimates 
that each form takes 1 hour to complete. DEA estimates that 495 
individual respondents will respond to this form. DEA estimates that 
1,346 responses are received annually.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: The total public burden for this collection is 
1,346 hours annually.
    If additional information is required contact: Lynn Bryant, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Patrick Henry 
Building, Suite 1600, 601 D Street, NW., Washington, DC 20530.

    Dated: June 12, 2007.
Lynn Bryant,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. E7-11783 Filed 6-18-07; 8:45 am]
BILLING CODE 4410-09-P